Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Saturday, October 31, 2026

Back to today

From X

@ChrisCamillo 3 clicks

Chris Camillo on X

One of the most important disciplines in investing is constantly updating the best argument against your own position. Not dismissing it. Not looking for reasons it’s wrong. Actually understanding it well enough to decide how much conviction your own thesis deserves. $AMZN has badly lagged the market and many other AI names recently, and I think the counter thesis has evolved. The biggest new threat is agentic commerce. Meta’s Muse and other AI agents could increasingly control product discovery and purchasing, potentially weakening Amazon’s retail and advertising moat. That’s real. But I think it plays out slowly, Amazon will adapt through its own agents, including Project Moonraker, or partnerships that are seeking access into and monetization from the world’s largest ecommerce platform, and in an agent-first world the upside to AWS, Trainium, Graviton and Amazon’s broader AI infrastructure business could ultimately more than offset the advertising dollars at risk. Then there’s Anthropic. A recent barrage of negative headlines around slowing growth and Meta/Microsoft reducing Claude usage has spilled over into $AMZN sentiment. Again, worth taking seriously. But much of that narrative looks incomplete. Anthropic’s revenue growth remains extraordinary, its IPO appears very much alive, and its massive long term commitment to AWS remains intact. We are still early and one can make a strong argument that AWS has more to gain from an open source first AI world than it would lose from Anthropic’s and OAI’s relative weakness, if it even plays out that way. And now sharply higher diesel prices create another near term headwind to Amazon’s shipping margins. That’s real too. But either fuel prices normalize or as with past cost inflation Amazon eventually passes much of the higher cost through while continuing to drive down fulfillment costs. I don’t need the counter thesis to be wrong to own $AMZN. I just need the bull thesis to be more right.
@StableBread

Fajasy on X

Alpayana, a private Peruvian mining group, asked for 19.9% of Magna Mining $MGMNF (TSX: $NICU) when management was “thinking something probably below 9.9,” per CEO Jason Jessup. On August 28, 2026, Alpayana, chaired by Alejandro Gubbins, bought 62,356,682 shares at CAD$2.25/share for US$99M. The US$99M more than quadrupled Magna’s cash at the time. Alpayana runs six underground mines in Peru and Mexico, most of them bought from other miners, including the Los Quenuales mines from Glencore $GLNCY in December 2022 and Sierra Metals, a copper-zinc miner, for ~US$176M in 2025. While it holds at least 10%, Alpayana can join future equity raises and top up after dilution, and it gets one board nominee or an observer. Jessup says Magna’s pre-deal plan already funded Levack, its flagship restart project, from cash and the cash flow of McCreedy West, its producing mine. So the US$99M mainly spares Magna from “delaying the startup construction at Crean Hill,” its permitted nickel mine, “by 1 or 2 years,” and gives it “a bit of a war chest” for acquisitions in Sudbury, Ontario, where its mines are. He also says Magna “could have five mines in production in 5 years and not have to ever do another financing again.” Neither restart study is out yet (both are due in the first half of October), so the claim rests on capital budgets investors haven’t seen. After the deal, Alpayana holds 19.9%, institutions 47.4%, retail investors 26.9%, and management and directors 5.8%. The institutional stake includes the 16.0% held by Dundee Corporation $DDEJF, a Toronto investment company.

Investor Letters

All letters

Microsoft's AI Boom Has A Cost

Microsoft’s Azure grew 48% as AI monetization accelerated, but doubled CapEx, largely for CPUs and GPUs, reduced quarterly free cash flow…

MSFT $3.9T
Yiannis Zourmpanos 2 clicks

CVX Earnings Review

Chevron’s Q3 revenue rose 35% to $65.2 billion and EBITDA 75% to $20.2 billion, while production trailed guidance and refining margins…

CVX $423B
Cestrian Capital Research 3 clicks

SNY Earnings Review

Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.

SNY $114B
Cestrian Capital Research 1 click

TSOH Weekly Roundup (10/30/2026)

Markel spent $315 million repurchasing shares in Q3 as Thrive agreed to buy ADT for $7.6 billion and Hasbro cited rising adult toy demand.

MKL $23B
TSOH Investment Research 1 click

AMZN Q3 FY12/26 Earnings Review

Amazon reported $201.9 billion Q3 revenue and 39% AWS growth, while $220 billion in 2026 capex drove trailing free cash flow to a $42.4…

AMZN $2.9T
Cestrian Capital Research 3 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 72 of 272

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

285 firms

Sectors

Ordered by how often our editor reaches for them.